XML 41 R27.htm IDEA: XBRL DOCUMENT v3.6.0.2
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2016
Income Taxes  
Schedule of Gross Deferred Tax Asset and Related Valuation Allowance

 

 

 

 

 

 

 

 

 

    

2016

    

2015

 

Deferred tax assets:

 

 

 

 

 

 

 

Net operating loss carryforward

 

$

34,451,814

 

$

24,745,536

 

Capitalized start-up costs

 

 

2,708,479

 

 

2,986,272

 

Patent amortization

 

 

216,203

 

 

238,378

 

Research and orphan drug credits

 

 

14,988,522

 

 

10,110,590

 

Deferred rent

 

 

123,744

 

 

96,107

 

Deferred compensation

 

 

2,107,964

 

 

1,206,920

 

Other

 

 

70,511

 

 

52,985

 

Total gross deferred tax assets

 

 

54,667,237

 

 

39,436,788

 

Valuation allowance

 

 

(54,667,237)

 

 

(39,436,788)

 

Deferred tax assets

 

 

 —

 

 

 —

 

Deferred tax liabilities:

 

 

 

 

 

 

 

Depreciation

 

 

 —

 

 

 —

 

Total deferred tax liabilities

 

 

 —

 

 

 —

 

 

 

 

 

 

 

 

 

Net deferred tax assets

 

$

 —

 

$

 —

 

 

Schedule of Reconciliations Between Statutory Federal Income Tax Rate and Effective Income Tax Rate of Income Tax Expense

 

 

 

 

 

 

 

 

 

    

2016

    

2015

    

2014

 

U.S. Federal statutory tax rate

 

34.0

%  

34.0

%  

34.0

%

State taxes

 

4.6

 

3.7

 

4.6

 

Research credit

 

1.0

 

5.6

 

7.4

 

Orphan drug credit

 

9.0

 

11.5

 

8.7

 

Stock-based compensation

 

(0.7)

 

(1.8)

 

(1.3)

 

Other

 

 —

 

 —

 

2.4

 

Change in valuation allowance

 

(47.9)

 

(53.0)

 

(55.8)

 

Provision for income taxes

 

 —

%

 —

%

 —

%